|Up a level|
Luo, C. and Gangadharan, V. and Bali, K.K. and Xie, R.G. and Agarwal, N. and Kurejova, M. and Tappe-Theodor, A. and Tegeder, I. and Feil, S. and Lewin, G. and Polgar, E. and Todd, A.J. and Schlossmann, Jens and Hofmann, F. and Liu, D.L. and Hu, S.J. and Feil, R. and Kuner, T. and Kuner, R. (2012) Presynaptically localized cyclic GMP-dependent Protein Kinase I is a key determinant of spinal potentiation and pain hypersensitivity. PLoS Biology 10 (3), 1e1001283.
Schmidtko, A. and Gao , W. and König, P. and Heine, S. and Motterlini, R. and Ruth, P. and Schlossmann, Jens and Koesling, D. and Niederberger, E. and Tegeder, I. and Friebe, A. and Geisslinger, G. (2008) cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I. Journal of Neuroscience 28, pp. 8568-8576.